User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 21:58, 18 December 2018 (diff | hist) . . (+907) . . m Non-small cell lung cancer (→Gemcitabine monotherapy {{#subobject:21a88f|Regimen=1}}) (current)
- 21:52, 18 December 2018 (diff | hist) . . (+1,514) . . m Colon cancer (→Fluorouracil & Folinic acid {{#subobject:a93a|Regimen=1}}) (current)
- 21:44, 18 December 2018 (diff | hist) . . (+703) . . m Breast cancer (→Epirubicin monotherapy {{#subobject:fda4d3|Regimen=1}}) (current)
- 21:40, 18 December 2018 (diff | hist) . . (+1,185) . . m Colon cancer (→IFL {{#subobject:544878|Regimen=1}})
- 20:29, 18 December 2018 (diff | hist) . . (+1,055) . . m Melanoma (→Temozolomide monotherapy {{#subobject:4e2652|Regimen=1}}) (current)
- 19:04, 18 December 2018 (diff | hist) . . (+863) . . m Acute myeloid leukemia (→Azacitidine monotherapy {{#subobject:791718|Regimen=1}}) (current)
- 18:53, 18 December 2018 (diff | hist) . . (+778) . . m Head and neck cancer (→Radiation therapy {{#subobject:5ac377|Regimen=1}}) (current)
- 18:46, 18 December 2018 (diff | hist) . . (+631) . . m Diffuse large B-cell lymphoma - historical (→CHOP {{#subobject:4ca454|Regimen=1}}) (current)
- 18:39, 18 December 2018 (diff | hist) . . (+845) . . m Multiple myeloma, consolidation and maintenance (→Tandem melphalan, then auto HSCT {{#subobject:dd75e9|Regimen=1}}) (current)
- 18:32, 18 December 2018 (diff | hist) . . (+761) . . m Renal cell carcinoma (→Interferon alfa-2a & Interleukin-2 {{#subobject:77d26e|Regimen=1}}) (current)
- 18:26, 18 December 2018 (diff | hist) . . (+987) . . m Breast cancer (→EC {{#subobject:3e1e8f|Regimen=1}})
- 17:10, 18 December 2018 (diff | hist) . . (+750) . . m Head and neck cancer (→Cisplatin & RT {{#subobject:c7061f|Regimen=1}})
- 17:06, 18 December 2018 (diff | hist) . . (+983) . . m Breast cancer, ER/PR-positive (→Tamoxifen monotherapy {{#subobject:2e0ab1|Regimen=1}}) (current)
- 16:59, 18 December 2018 (diff | hist) . . (+750) . . m Non-small cell lung cancer (→Carboplatin, Paclitaxel, RT {{#subobject:899399|Regimen=1}})
- 16:53, 18 December 2018 (diff | hist) . . (+949) . . m Breast cancer (→AC {{#subobject:77b0fd|Regimen=1}})
- 16:51, 18 December 2018 (diff | hist) . . (+1,488) . . m Complex multipart regimens (→Mavroudis et al. 2017) (current)
- 16:42, 18 December 2018 (diff | hist) . . (+828) . . m Head and neck cancer (→Cisplatin & RT {{#subobject:c7061f|Regimen=1}})
- 16:37, 18 December 2018 (diff | hist) . . (+912) . . m Non-small cell lung cancer (→Observation)
- 16:30, 18 December 2018 (diff | hist) . . (+844) . . m Breast cancer (→Observation)
- 16:26, 18 December 2018 (diff | hist) . . (+759) . . m Small cell lung cancer (→Cisplatin & Etoposide {{#subobject:ec90cd|Regimen=1}}) (current)
- 16:20, 18 December 2018 (diff | hist) . . (+1,485) . . m Non-small cell lung cancer (→Cisplatin, Docetaxel, RT {{#subobject:6d901b|Regimen=1}})
- 16:14, 18 December 2018 (diff | hist) . . (+793) . . m Glioblastoma (→Gliadel wafer {{#subobject:3fdb9e|Regimen=1}}) (current)
- 16:10, 18 December 2018 (diff | hist) . . (+1,921) . . m Breast cancer (→AC {{#subobject:647f67|Regimen=1}})
- 16:02, 18 December 2018 (diff | hist) . . (+706) . . m Breast cancer (→FEC {{#subobject:3613b7|Regimen=1}})
- 15:56, 18 December 2018 (diff | hist) . . (+671) . . m Testicular cancer (→BEP {{#subobject:d2918b|Regimen=1}}) (current)
- 14:42, 18 December 2018 (diff | hist) . . (+893) . . m Ovarian cancer (→Carboplatin & Paclitaxel {{#subobject:dd35ee|Regimen=1}}) (current)
- 14:32, 18 December 2018 (diff | hist) . . (+1,564) . . m Ovarian cancer - historical (→Intraperitoneal therapy) (current)
- 14:25, 18 December 2018 (diff | hist) . . (+957) . . m Colon cancer (→FOLFIRI {{#subobject:ebcf30|Regimen=1}})
- 14:05, 18 December 2018 (diff | hist) . . (0) . . m Tagraxofusp (Elzonris) (Jwarner moved page SL-401 to Tagraxofusp (Elzonris): Generic name available) (current)
- 14:05, 18 December 2018 (diff | hist) . . (+36) . . N SL-401 (Jwarner moved page SL-401 to Tagraxofusp (Elzonris): Generic name available) (current)
- 14:05, 18 December 2018 (diff | hist) . . (+72) . . m Tagraxofusp (Elzonris)
- 14:04, 18 December 2018 (diff | hist) . . (+5) . . m Tagraxofusp (Elzonris)
- 14:03, 18 December 2018 (diff | hist) . . (-111) . . m Drug index (→Alphabetically) (current)
- 14:02, 18 December 2018 (diff | hist) . . (0) . . m Denintuzumab mafodotin (SGN-CD19A) (Jwarner moved page SGN-CD19A to Denintuzumab mafodotin (SGN-CD19A): Generic name available) (current)
- 14:02, 18 December 2018 (diff | hist) . . (+48) . . N SGN-CD19A (Jwarner moved page SGN-CD19A to Denintuzumab mafodotin (SGN-CD19A): Generic name available) (current)
- 14:02, 18 December 2018 (diff | hist) . . (-9) . . m Denintuzumab mafodotin (SGN-CD19A)
- 14:00, 18 December 2018 (diff | hist) . . (-6) . . m MOR202 (current)
- 14:00, 18 December 2018 (diff | hist) . . (-3) . . m MOR202
- 13:57, 18 December 2018 (diff | hist) . . (0) . . m Spebrutinib (CC-292) (Jwarner moved page CC-292 (AVL-292) to Spebrutinib (CC-292): Generic name available) (current)
- 13:57, 18 December 2018 (diff | hist) . . (+34) . . N CC-292 (AVL-292) (Jwarner moved page CC-292 (AVL-292) to Spebrutinib (CC-292): Generic name available) (current)
- 13:57, 18 December 2018 (diff | hist) . . (+56) . . m Spebrutinib (CC-292)
- 13:23, 18 December 2018 (diff | hist) . . (+1,563) . . m Acute myeloid leukemia - historical (→Panobinostat monotherapy {{#subobject:ce9c31|Regimen=1}}) (current)
- 13:17, 18 December 2018 (diff | hist) . . (+1,103) . . m Acute myeloid leukemia (→7+3d (intermediate-dose) {{#subobject:e82156|Regimen=1}})
- 13:08, 18 December 2018 (diff | hist) . . (+888) . . m Acute myeloid leukemia (→7+3d (standard-dose) {{#subobject:9f31ad|Regimen=1}})
- 11:23, 18 December 2018 (diff | hist) . . (+654) . . m Non-small cell lung cancer (→Carboplatin & Paclitaxel {{#subobject:c5fbdf|Regimen=1}})
- 11:19, 18 December 2018 (diff | hist) . . (+1,042) . . m Breast cancer (→Epirubicin monotherapy {{#subobject:fda4d3|Regimen=1}})
- 10:50, 18 December 2018 (diff | hist) . . (+1,455) . . m Bladder cancer (→Gemcitabine & Paclitaxel {{#subobject:ecfc0d|Regimen=1}}) (current)
- 10:44, 18 December 2018 (diff | hist) . . (+1,219) . . m Ovarian cancer - historical (→Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}})
- 10:34, 18 December 2018 (diff | hist) . . (+2,298) . . m Breast cancer (→Epirubicin monotherapy {{#subobject:fda4d3|Regimen=1}})
- 10:31, 18 December 2018 (diff | hist) . . (+2,680) . . m Complex multipart regimens (→GIM2)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
